Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. September 2019 03:12 ET | Quelle: Adroit Market Research

Online Music Learning Market to Hit 143.3 Mn by 2025 – Global Insights On Key Trends, Recent Developments, Drivers, Restraints, Top Brands, and Regional Overview: Adroit Market Research

Dallas,Texas, Sept. 30, 2019 (GLOBE NEWSWIRE) -- The “Global Online Music Learning Market Size by Region (North America, Europe, Asia Pacific and Rest of the World), Forecast 2018 to 2025” study...
30. September 2019 02:35 ET | Quelle: ASLAN PHARMACEUTICALS LIMITED

ASLAN Pharmaceuticals and Bukwang Pharmaceutical Establish a Joint Venture, JAGUAHR Therapeutics, to Develop Novel Immuno-Oncology Therapies

- ASLAN spins out pre-clinical assets in joint venture with Bukwang to form JAGUAHR Therapeutics with Bukwang investing up to US$5 million - ASLAN and Bukwang will co-own new entity to develop novel...
30. September 2019 02:34 ET | Quelle: Adroit Market Research

Sheet Face Masks Market to hit 448.6 Mn by 2025 – Global Insights on Trends, Vendor Landscape, Product Type, Skin Concern, Distribution Channel, Value Chain & Opportunities: Adroit Market Research

Dallas, Texas, Sept. 30, 2019 (GLOBE NEWSWIRE) -- The “Global Sheet Face Masks Market Size by Product (Microfiber sheet masks, Hydrogel sheet masks, Bio-cellulose masks, Clay sheet masks); by Skin...
30. September 2019 02:30 ET | Quelle: F. Hoffmann-La Roche Ltd

Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa

Efficacy of Alecensa® (alectinib) in people identified to have ALK-positive non-small cell lung cancer using liquid biopsy is consistent with efficacy in those identified by tissue analysis in the...
30. September 2019 02:13 ET | Quelle: Adroit Market Research

Sauces, Dressings and Condiments Market to grow at 4.2% CAGR during (2019-2025) – Global Analysis by Value Chain, Consumer Behavior, Pricing, Strategic Framework, Recent Initiatives and Opportunities: Adroit Market Research

Dallas, Texas, Sept. 30, 2019 (GLOBE NEWSWIRE) -- The “Global Sauces, dressings and condiments Market Size 2018 by Type (Sauces, Dressings, Condiments, Syrups & Spreads, seasoning mixes,...
30. September 2019 02:05 ET | Quelle: Impact Partners

Sunstone announce new investment in immuno-oncology company STipe Therapeutics

NEWS RELEASE Sunstone announce new investment in immuno-oncology company STipe Therapeutics Copenhagen, 30 September 2019 – Sunstone Life Science Ventures today announce it has invested in...
30. September 2019 02:00 ET | Quelle: Vast Resources PLC

Annual Financial Report

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining 30 September 2019 Vast Resources plc (“Vast” or the “Company”) Posting of Annual Report Vast Resources plc, the AIM-listed mining...
30. September 2019 02:00 ET | Quelle: OSE Immunotherapeutics

OSE Immunotherapeutics Presents New Preclinical Data on its Novel Bispecific Checkpoint Inhibitor (BiCKI®) Platform Targeting PD-1 and Cytokines to Overcome Tumor Resistance to Checkpoint Inhibitor Blockade

NANTES, France, Sept. 30, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Euronext: OSE) presented new data on its BiCKI® platform at the International Cancer Immunotherapy...
30. September 2019 01:47 ET | Quelle: Adroit Market Research

VNA and PACS Market to grow at 7.3% CAGR during (2019-2025) – Insights on Modality, Recent Developments, Restraints, Drivers, Top Players, and Key Opportunities: Adroit Market Research

Dallas, Texas, Sept. 30, 2019 (GLOBE NEWSWIRE) -- The “Global VNA & PACS Market Size 2018 by Type (Vendor Neutral Archive (VNA) & Picture Archiving & Communication System (PACS)), by...
30. September 2019 01:30 ET | Quelle: VALNEVA

Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine Candidate VLA15

Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine Candidate VLA15 Saint-Herblain (France), September 30, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company...

Vorherige Seite

Nächste Seite